BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 28843020)

  • 21. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of parkinsonism.
    Facca AG; Koller WC
    Adv Neurol; 2003; 91():383-96. PubMed ID: 12442697
    [No Abstract]   [Full Text] [Related]  

  • 24. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.
    Colosimo C; Morgante L; Antonini A; Barone P; Avarello TP; Bottacchi E; Cannas A; Ceravolo MG; Ceravolo R; Cicarelli G; Gaglio RM; Giglia L; Iemolo F; Manfredi M; Meco G; Nicoletti A; Pederzoli M; Petrone A; Pisani A; Pontieri FE; Quatrale R; Ramat S; Scala R; Volpe G; Zappulla S; Bentivoglio AR; Stocchi F; Trianni G; Del Dotto P; Simoni L; Marconi R;
    J Neurol; 2010 Jan; 257(1):5-14. PubMed ID: 19669613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetics of disorders with synuclein pathology and parkinsonism.
    Farrer M; Gwinn-Hardy K; Hutton M; Hardy J
    Hum Mol Genet; 1999; 8(10):1901-5. PubMed ID: 10469843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anal sphincter electromyography in patients with newly diagnosed idiopathic parkinsonism.
    Linder J; Libelius R; Nordh E; Holmberg B; Stenlund H; Forsgren L
    Acta Neurol Scand; 2012 Oct; 126(4):248-55. PubMed ID: 22211900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of parkinsonism syndromes by general neurologists.
    Joutsa J; Gardberg M; Röyttä M; Kaasinen V
    Parkinsonism Relat Disord; 2014 Aug; 20(8):840-4. PubMed ID: 24816002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.
    Deverdun J; Menjot de Champfleur S; Cabello-Aguilar S; Maury F; Molino F; Charif M; Leboucq N; Ayrignac X; Labauge P; Bonafe A; Castelnovo G; Le Bars E; Geny C; Menjot de Champfleur N
    Eur J Radiol; 2014 Nov; 83(11):2074-9. PubMed ID: 25154005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive supranuclear palsy phenotype mimicking synucleinopathies.
    Menšíková K; Matěj R; Tučková L; Rusina R; Ehrmann J; Kaňovský P
    J Neurol Sci; 2013 Jun; 329(1-2):34-7. PubMed ID: 23590894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients.
    Toyoshima Y; Takahashi H; Katada S; Kojima N; Tada M; Tani T; Koike R; Nozawa T; Aida I; Nakajima T; Onodera O; Kakita A
    Neuropathology; 2021 Dec; 41(6):450-456. PubMed ID: 34779072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.
    Bower JH; Maraganore DM; McDonnell SK; Rocca WA
    Neurology; 1997 Nov; 49(5):1284-8. PubMed ID: 9371909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.
    Yang W; Woltjer RL; Sokal I; Pan C; Wang Y; Brodey M; Peskind ER; Leverenz JB; Zhang J; Perl DP; Galasko DR; Montine TJ
    Am J Pathol; 2007 Sep; 171(3):993-1002. PubMed ID: 17675576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing disease progression with MRI in atypical parkinsonian disorders.
    Köllensperger M; Wenning GK
    Mov Disord; 2009; 24 Suppl 2():S699-702. PubMed ID: 19877233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic correlates of supranuclear gaze palsy with parkinsonism.
    Martin WRW; Hartlein J; Racette BA; Cairns N; Perlmutter JS
    Parkinsonism Relat Disord; 2017 May; 38():68-71. PubMed ID: 28256434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical parkinsonian syndromes in a North African tertiary referral center.
    Nasri A; Ben Djebara M; Sghaier I; Mrabet S; Zidi S; Gargouri A; Kacem I; Gouider R
    Brain Behav; 2021 Jan; 11(1):e01924. PubMed ID: 33179436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.
    Scholz SW; Bras J
    Int J Mol Sci; 2015 Oct; 16(10):24629-55. PubMed ID: 26501269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic susceptibility variants in parkinsonism.
    Soto-Ortolaza AI; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.